Danielle is the Head of the Regulatory Affairs Americas team at the Coalition for Epidemic Preparedness innovations. She studied genomics and molecular genetics at Michigan State University before starting her career in quality and regulatory affairs. Prior to joining CEPI, she worked in the pharmaceutical industry leading regulatory strategies for Phase 1 to Phase 4 programs for medical products, including vaccines, monoclonal antibodies, immunoglobulins and plasma-derived products. In her current role, she partners with vaccine developers and regulators to further CEPI’s mission of accelerating “the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines for people during outbreaks.”